Understanding drug allergies

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 6 6 II, 2000, Pages S637-S644

  Gruchalla, Rebecca ^a  

^a NONE   (United States)

Author keywords

Adverse drug reactions; Allergic drug reactions; Drug allergy; Drug desensitization; Haptens; Hypersensitivity reactions; Toxicity

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; HAPTEN; IMMUNOGLOBULIN E; LATEX; PARACETAMOL; PENICILLIN G; PENTAMIDINE; SULFAMETHOXAZOLE; SULFONAMIDE; TUBERCULOSTATIC AGENT; VANCOMYCIN; WARFARIN;

ALLERGY TEST; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFERENCE PAPER; DESENSITIZATION; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; DRUG WITHDRAWAL; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; PRIORITY JOURNAL; PROVOCATION TEST;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG HYPERSENSITIVITY; HUMANS;

EID: 0034123722     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106156     Document Type: Article

References (32)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 279:1998;1200-1205.
2. DeShazo R, Kemp S. Allergic reactions to drugs and biologic agents. JAMA. 278:1997;1895-1906.
3. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 152, 438 consecutive inpatients, 1975 to 1982. JAMA. 256:1986;3358-3363.
4. Hunziker T, Kunzi U, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring: adverse drug reactions: a 20-year survey. Allergy. 52:1997;388-393.
5. Bernstein, IL, Gruchalla, RS, Lee, RE, Nicklas, RA, Dykewicz, MS1999Disease management of drug hypersensitivity: a practice parameter.
6. Meekins CV, Sullivan TJ, Gruchalla RS. Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted serum proteins. J Allergy Clin Immunol. 94:1994;1017-1024.
7. Gruchalla RS, Pesenko RD, Do TT, Skiest DJ. Sulfonamide-induced reactions in desensitized patients with AIDS: the role of covalent protein haptenation by sulfamethoxazole. J Allergy Clin Immunol. 101:1998;371-378.
8. Kearns G, Wheeler GJ, Childress SH, Letzig LG. Serum-sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr. 125:1994;805-811.
9. Coombs, R, Gell, PGH, 1975, Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell P, Coombs RRA, Lachman PJ, editors. Clinical aspects of immunology.
10. Sullivan, TJ, 1993, Drug allergy. In: Middleton EJ, Reed CE, Ellis EF, et al, editors. Allergy: principles and practice.
11. Rieder MJ, Krause R, Bird IA, Dekaban GA. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J Acquir Immune Defic Syndr Hum Retrovirol. 8:1995;134-140.
12. Rieder MJ, Uetrecht J, Shear NH, Spielberg SP. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J Pharmacol Exp Ther. 244:1988;724-728.
13. Park B, Coleman J, Kitteringham N. Drug disposition and drug hypersensitivity. Biochem Pharmacol. 36:1987;581-590.
14. Kenna JG. The molecular basis of halothane-induced hepatitis. Biochem Soc Trans. 19:1990;191-195.
15. Martin JL, Kenna JG, Martin BM, Thomassen D, Reed GF, Pohl LR. Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase. Hepatology. 18:1993;858-863.
16. Physicians' Desk, 3346, Montvale (NJ): Medical Economics; 1999. p.
17. Litt, J, Pawlak, WA, 1995, Drug eruption reference manual.
18. Shear NH. Diagnosing cutaneous adverse reactions to drugs [editorial]. Arch Dermatol. 126:1990;94-97.
19. Solensky, R, Earl, H, Gruchalla, R1999Clinical approach to penicillin allergic patients: a survey [abstract].
20. Weiss ME, Adkinson NF. Diagnostic testing for drug hypersensitivity. Immunol Allergy Clin North Am. 18:1998;731-744.
21. Brandt, M, Gruchalla, RS, Sullivan, T1993Skin-testing and in vitro testing to detect IgE to antimicrobial drugs [abstract].
22. Empedrad, RB, Earl, HS, Gruchalla, RS2000Determiniation of nonirritating skin test concentrations of commonly used antimicrobial drugs (abstract].
23. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy. 27:1997;175-181.
24. Spielberg SP. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc. 43:1984;2303-2313.
25. Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 32:1992;897-904.
26. Absar N, Daneshuar H, Beall G. Desensitization to trimethoprim/sulfamethoxazole in the HIV-infected patients. J Allergy Clin Immunol. 93:1994;1001-1005.
27. Sullivan TJ. Antigen-specific desensitization to prevent allergic reactions to drugs [editorial]. Ann Allergy. 73:1994;375-377.
28. Anne S, Middleton E, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy. 73:1994;402-404.
29. Gruchalla, RS, 1998, Acute drug desensitization.
30. Knowles S, Shapiro L, Shear NH. Serious dermatologic reactions in children. Curr Opin Pediatr. 9:1997;388-395.
31. Sullivan, TJ, Ong, RC, Gilliam, LK1989Studies of the multiple drug allergy syndrome [abstract].
32. Khoury L, Warrington R. The multiple drug allergy syndrome: a matched-control retrospective study in patients allergic to penicillin. J Allergy Clin Immunol. 98:1996;462-464.